Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs.

Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs.
复制标题

DOI:
10.3390/pharmaceutics13030388
复制
发表时间:
2021-03-15
期刊:
影响因子:
5.4
通讯作者:
Fujita T
Fujita T
中科院分区:
医学2区
文献类型:
--
作者:
Kono Y;Kawahara I;Shinozaki K;Nomura I;Marutani H;Yamamoto A;Fujita T

文献摘要

参考文献

被引文献

相似文献

为了开发口服药物,准确预测新化学物质的口服吸收是非常必要的。然而,由于包括P-糖蛋白(P-gp)在内的外排转运体参与了它们的吸收过程,这是很困难的。本研究比较分析了7种P-gp抑制剂(环孢菌素A、GF120918、LY335979、XR9576、WK-X-34、VX-710和OC144-093)对药物吸收的抑制作用。GF120918、LY335979和XR9576显著降低了P-gp底物紫杉醇通过Caco-2细胞单层的基底端到顶端的转运。GF120918还抑制了乳腺癌耐药蛋白(BCRP)底物米托蒽酮在Caco-2细胞中从底部到顶端的转运,而LY335979几乎不影响米托蒽酮的转运。此外,LY335979可显著提高野生型小鼠口服紫杉醇的吸收速率,与mdr1a/1b基因敲除小鼠相似。此外,野生型小鼠经LY335979处理后,BCRP底物拓扑替康的吸收速率与mdr1a/1b基因敲除小鼠相似,但显著低于BCRP基因敲除小鼠。这些结果表明,LY335979对P-gp具有选择性抑制活性,可用于评价P-gp对药物吸收的贡献。
For developing oral drugs, it is necessary to predict the oral absorption of new chemical entities accurately. However, it is difficult because of the involvement of efflux transporters, including P-glycoprotein (P-gp), in their absorption process. In this study, we conducted a comparative analysis on the inhibitory activities of seven P-gp inhibitors (cyclosporin A, GF120918, LY335979, XR9576, WK-X-34, VX-710, and OC144-093) to evaluate the effect of P-gp on drug absorption. GF120918, LY335979, and XR9576 significantly decreased the basal-to-apical transport of paclitaxel, a P-gp substrate, across Caco-2 cell monolayers. GF120918 also inhibited the basal-to-apical transport of mitoxantrone, a breast cancer resistance protein (BCRP) substrate, in Caco-2 cells, whereas LY335979 hardly affected the mitoxantrone transport. In addition, the absorption rate of paclitaxel after oral administration in wild-type mice was significantly increased by pretreatment with LY335979, and it was similar to that in mdr1a/1b knockout mice. Moreover, the absorption rate of topotecan, a BCRP substrate, in wild-type mice pretreated with LY335979 was similar to that in mdr1a/1b knockout mice but significantly lower than that in bcrp knockout mice. These results indicate that LY335979 has a selective inhibitory activity for P-gp, and would be useful for evaluating the contribution of P-gp to drug absorption.
DOI: 10.1023/b:drug.0000026248.45084.21
发表时间: 2004-08-01
影响因子: 3.4
作者:
Bardelmeijer, HA;Ouwehand, M;van Tellingen, O
通讯作者: van Tellingen, O
DOI: 10.1158/1078-0432.ccr-08-2253
发表时间: 2009-04-01
影响因子: 11.5
作者:
Lagas, Jurjen S.;van Waterschoot, Robert A. B.;Schinkel, Alfred H.
通讯作者: Schinkel, Alfred H.
DOI: 10.1158/1078-0432.ccr-07-1335
发表时间: 2007-11-01
影响因子: 11.5
作者:
de Vries, Nienke A.;Zhao, Jin;van Tellingen, Olaf
通讯作者: van Tellingen, Olaf
DOI: 10.1007/s00280-002-0542-3
发表时间: 2003-02-01
影响因子: 3
作者:
Callies, S;de Alwis, DP;Aarons, L
通讯作者: Aarons, L
DOI: 10.1016/j.bmc.2016.05.039
发表时间: 2016-07-15
影响因子: 3.5
作者:
Miyata, Ken-ichi;Nakagawa, Yoshiaki;Akamatsu, Miki
通讯作者: Akamatsu, Miki